Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
EV/Core EBITDA

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 29.7314.3411.4411.2112.77

What is the latest EV/Core EBITDA ratio of INDOCO REMEDIES ?

The latest EV/Core EBITDA ratio of INDOCO REMEDIES is 29.73 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202529.73
Mar202414.34
Mar202311.44
Mar202211.21
Mar202112.77

How is EV/Core EBITDA of INDOCO REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2025 29.73
107.32
Mar2024 14.34
25.35
Mar2023 11.44
2.05
Mar2022 11.21
-12.22
Mar2021 12.77 -

Other Financial Ratios of INDOCO REMEDIES


Compare EV/Core EBITDA ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,583.4 Cr -0.8% -3.5% -9.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,751.0 Cr 0.2% 7.1% -7.7% Stock Analytics
DIVIS LABORATORIES ₹176,634.0 Cr 1% 16.8% 12.7% Stock Analytics
CIPLA ₹124,437.0 Cr -2.7% 3.5% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,871.0 Cr 0.6% 0.4% 4.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,333.0 Cr -6.4% -2.7% -3.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-0.8%

-3.5%

-9.2%

SENSEX

-0.2%

5%

5.4%


You may also like the below Video Courses